(30-Second Orientation) TRIUMPH is the name Eli Lilly gives to its Phase 3 retatrutide trial program
GLP-1R modulation on homologous neural circuits in the rhesus macaque is a viable candidate mechanism for the observed anorectic effects of Ex in the current study
If youre enrolled in Medicare and discussing a GLP-1 with your doctor, youll want to make sure you understand your plans formulary and out-of-pocket costs and include that in your conversations with your doctor
Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
Pills may widen access, not solve the problem Oral GLP-1s could draw interest from employees who dislike injections or see pills as an easier first step